Abbonarsi

Initial evaluation of a novel, prototype, forward-viewing echoendoscope in a porcine arterial bleeding model (with video) - 24/08/11

Doi : 10.1016/j.gie.2010.04.053 
B. Joseph Elmunzer, MD , Michael J. Pollack, MD , Joseph A. Trunzo, MD, Steve J. Schomisch, PhD, Richard C. Wong, MD, Ashley L. Faulx, MD, Gerard A. Isenberg, MD, Jeffrey L. Ponsky, MD, Jeffrey M. Marks, MD, Amitabh Chak, MD
Current affiliations: Division of Gastroenterology (B.J.E.), University of Michigan Medical Center, Ann Arbor, Michigan; Division of Gastroenterology (M.J.P., R.C.W., A.L.F., G.A.I., A.C.), Department of Surgery (J.A.T., S.J.S., J.L.P., J.M.M.), University Hospitals Case Medical Center, Cleveland, Ohio, USA 

Reprint requests: B. Joseph Elmunzer, MD, University of Michigan Medical Center, 3912 Taubman Center, Ann Arbor, MI 48109

Riassunto

Background

Real-time visualization of submucosal arterial flow at the base of an ulcer might improve endoscopic hemostasis by permitting more accurate assessment of the artery, precise targeting of therapy, and confirmation of vessel ablation.

Objective

To evaluate the utility of a novel, forward-viewing echoendoscope in identifying bleeding submucosal arteries, guiding hemostatic therapy, and confirming cessation of flow through treated vessels.

Design

In 7 pigs, a previously described porcine model for peptic ulcer hemorrhage was created by isolating the gastroepiploic and/or short gastric artery and tunneling it into the subserosal space at laparotomy.

Setting

Animal research facility.

Intervention

The prototype endoscope was used to image submucosal arterial flow. EUS guidance was then used to deliver endoscopic hemostatic therapy and assess treatment adequacy.

Main Outcome Measurements

Identification of the target submucosal artery and successful delivery of EUS-guided endoscopic therapy, evidenced by cessation of Doppler flow through the target vessel.

Results

Tunneled arteries were visualized endosonographically in all 7 cases. EUS-guided submucosal injection of epinephrine was successful in 2 of 2 cases. EUS-guided delivery of thermal hemostatic therapy was successful in 2 of 4 cases. Absence of flow through treated vessels was confirmed in cases in which EUS-guided therapy was successfully delivered.

Limitations

Acute animal model.

Conclusion

Proof of principle experiments in a porcine peptic ulcer hemorrhage model suggest that real-time sonographic imaging of submucosal arteries is feasible with a forward-viewing echoendoscope, and guided hemostatic therapy can be delivered.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 DISCLOSURE: A. Chak disclosed receipt of research support from Olympus America. The forward-viewing echoendoscope was provided by Olympus Inc (Tokyo, Japan). The multipolar electrocautery probes and sclerotherapy needles were provided by Boston Scientific Corp (Natick, Mass). No other financial relationships relevant to this publication were disclosed.
 If you would like to chat with an author of this article, you may contact Dr Elmunzer at badihe@umich.edu.


© 2010  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 72 - N° 3

P. 611-614 - settembre 2010 Ritorno al numero
Articolo precedente Articolo precedente
  • Use of the front-view forward-array echoendoscope to evaluate right colonic subepithelial lesions
  • Thai Nguyen-Tang, Janak N. Shah, Andres Sanchez-Yague, Kenneth F. Binmoeller
| Articolo seguente Articolo seguente
  • Gastric perforations after ligation of GI stromal tumors in the gastric fundus
  • Sun Siyu, Wang Sheng, Wang Guoxin, Ge Nan, Liu Jingang

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.